Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,140
datasets available to search
ShareScore release 0.9.0
Dataset results
1,140 results for “TOPS”
GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
ClinicalTrials.gov study NCT00707031. IPD Sharing: Not stated. Countries: 18. Publications: 2.
GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
ClinicalTrials.gov study NCT00712673. IPD Sharing: Not stated. Countries: 16. Publications: 4.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
ClinicalTrials.gov study NCT00763815. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)
ClinicalTrials.gov study NCT01617655. IPD Sharing: Not stated. Countries: 5. Publications: 7.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
ClinicalTrials.gov study NCT00715624. IPD Sharing: Not stated. Countries: 15. Publications: 4.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
ClinicalTrials.gov study NCT00866658. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
ClinicalTrials.gov study NCT03405792. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT01476475. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)
ClinicalTrials.gov study NCT01644188. IPD Sharing: Not stated. Countries: 10. Publications: 5.
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)
ClinicalTrials.gov study NCT00772538. IPD Sharing: Not stated. Countries: 14. Publications: 4.
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
ClinicalTrials.gov study NCT01206166. IPD Sharing: Not stated. Countries: 4. Publications: 6.
Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
ClinicalTrials.gov study NCT02058147. IPD Sharing: Not stated. Countries: 23. Publications: 8.
The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery
ClinicalTrials.gov study NCT04474366. IPD Sharing: YES. Countries: 1. Publications: 5.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
ClinicalTrials.gov study NCT00713830. IPD Sharing: Not stated. Countries: 16. Publications: 4.
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
ClinicalTrials.gov study NCT01644175. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
ClinicalTrials.gov study NCT00124748. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)
ClinicalTrials.gov study NCT00776984. IPD Sharing: Not stated. Countries: 15. Publications: 4.
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
ClinicalTrials.gov study NCT01151137. IPD Sharing: Not stated. Countries: 37. Publications: 2.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
ClinicalTrials.gov study NCT00763451. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT01768559. IPD Sharing: Not stated. Countries: 18. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.